KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)R&D In ProcessReceivables - NetShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Pfizer (PFE) Short-Term Debt repayments (2016 - 2025)

Pfizer has reported Short-Term Debt repayments over the past 13 years, most recently at $151.0 million for Q2 2025.

  • Quarterly Short-Term Debt repayments fell 96.66% to $151.0 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $151.0 million through Mar 2026, down 98.97% year-over-year, with the annual reading at $2.2 billion for FY2025, 80.41% down from the prior year.
  • Short-Term Debt repayments was $151.0 million for Q2 2025 at Pfizer, down from $2.0 billion in the prior quarter.
  • Over five years, Short-Term Debt repayments peaked at $7.8 billion in Q3 2024 and troughed at $1.0 million in Q4 2021.
  • The 5-year median for Short-Term Debt repayments is $1.2 billion (2024), against an average of $2.3 billion.
  • Year-over-year, Short-Term Debt repayments plummeted 99.99% in 2021 and then surged 388600.0% in 2022.
  • A 5-year view of Short-Term Debt repayments shows it stood at $1.0 million in 2021, then surged by 388600.0% to $3.9 billion in 2022, then plummeted by 99.92% to $3.0 million in 2023, then surged by 259033.33% to $7.8 billion in 2024, then plummeted by 98.06% to $151.0 million in 2025.
  • Per Business Quant, the three most recent readings for PFE's Short-Term Debt repayments are $151.0 million (Q2 2025), $2.0 billion (Q1 2025), and $7.8 billion (Q3 2024).